Agilon Health, Inc. (NYSE:AGL) Receives Consensus Rating of “Hold” from Analysts

Agilon Health, Inc. (NYSE:AGL) has received an average rating of “Hold” from the fifteen analysts that are currently covering the firm, Marketbeat.com reports. Two research analysts have rated the stock with a sell recommendation, seven have assigned a hold recommendation and six have given a buy recommendation to the company. The average 1-year price objective among analysts that have issued a report on the stock in the last year is $102.25.

A number of brokerages have recently issued reports on AGL. JPMorgan Chase & Co. upped their target price on shares of Agilon Health from $31.00 to $85.00 and gave the company an “underweight” rating in a report on Monday, August 24th. Robert W. Baird set a $116.00 price target on Agilon Health in a report on Thursday, August 6th. Sanford C. Bernstein raised Agilon Health from a “market perform” rating to an “outperform” rating and boosted their price target for the stock from $86.00 to $125.00 in a research report on Tuesday. Royal Bank Of Canada set a $125.00 price objective on Agilon Health in a research note on Tuesday. Finally, Truist Financial set a $112.00 price objective on Agilon Health and gave the company a “hold” rating in a research report on Thursday, August 6th.

Agilon Health Price Performance

Shares of AGL opened at $91.73 on Friday. The company has a current ratio of 1.08, a quick ratio of 1.08 and a debt-to-equity ratio of 0.07. The company’s fifty day simple moving average is $99.15 and its 200 day simple moving average is $70.63. Agilon Health has a 1-year low of $7.48 and a 1-year high of $133.04. The company has a market cap of $1.54 billion, a price-to-earnings ratio of -6.43 and a beta of 3.02.

Agilon Health (NYSE:AGL) last announced its quarterly earnings results on Wednesday, August 5th. The company reported $1.04 EPS for the quarter, beating analysts’ consensus estimates of $0.14 by $0.90. Agilon Health had a negative net margin of 3.92% and a negative return on equity of 119.38%. The firm had revenue of $1.49 billion during the quarter, compared to analysts’ expectations of $1.45 billion. On average, research analysts forecast that Agilon Health will post -2.9 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Agilon Health

A number of large investors have recently added to or reduced their stakes in AGL. The Manufacturers Life Insurance Company acquired a new stake in Agilon Health during the 2nd quarter valued at $355,000. Tidal Investments LLC acquired a new position in shares of Agilon Health in the second quarter valued at $1,405,000. Engineers Gate Manager LP acquired a new position in shares of Agilon Health in the second quarter valued at $516,000. Integrated Wealth Concepts LLC bought a new position in shares of Agilon Health in the second quarter valued at about $384,000. Finally, Squarepoint Ops LLC bought a new position in shares of Agilon Health in the second quarter valued at about $407,000.

Agilon Health Company Profile

Agilon Health, Inc is a healthcare company that partners with independent primary care physicians to support the transition from fee-for-service medicine to value-based care. The company focuses primarily on patients enrolled in Medicare Advantage plans and works with physician groups to coordinate care, improve outcomes and manage healthcare costs.

Agilon provides physicians with technology, analytics, operational support and clinical resources designed to help them manage the health of defined patient populations.